Russell Berg

Russell Berg is the Executive Director of Biosimilars Global Study Management at Amgen, a position held since 2019. With over 30 years in the biotechnology and pharmaceutical industry, they have previously served in roles such as Director of Clinical Development for the XGEVA® oncology program and Director of Global Study Management for Oncology/Hematology Biosimilars. Russell earned a B.Sc. in Organic Chemistry from the University of Guelph and a Master's in Business Administration from Pepperdine Graziadio Business School. Throughout their career, they have focused on excellence in clinical trial execution and the development of high-performing teams.